UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$78,614,678
-$4,838,768 QoQ
Shares Held
964,479
-27.5% QoQ
Ownership
0.683%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 497 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ARWR ranks #11 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,614,678 | 964,479 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $83,453,446 | 1,330,996 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $83,676,623 | 1,260,380 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $60,684,772 | 1,759,489 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,412,206 | 2,684,317 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $60,961,686 | 4,785,062 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $37,790,423 | 2,010,129 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,727,819 | 2,154,250 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $59,521,095 | 2,290,154 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,709,536 | 933,900 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $29,109,593 | 951,294 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,907,494 | 740,882 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $19,148,168 | 536,965 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,638,909 | 536,965 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,195,673 | 497,921 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,854,195 | 86,360 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,863,414 | 109,725 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,237,615 | 113,886 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,438,324 | 97,109 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,148,853 | 98,492 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,260,081 | 87,661 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,064,777 | 91,461 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $4,569,482 | 106,119 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,542,463 | 105,174 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,557,564 | 88,897 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||